首页> 美国卫生研究院文献>Nucleic Acids Research >A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune–Albright syndrome
【2h】

A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune–Albright syndrome

机译:一种基于PNA杂交探针和FRET原理的新技术用于量化纤维异型增生/ McCune-Albright综合征的突变基因型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Somatic mutations are present in various proportions in numerous developmental pathologies. Somatic activating missense mutations of the GNAS gene encoding the Gsα protein have previously been shown to be the cause of fibrous dysplasia of bone (FD)/McCune-Albright syndrome (MAS). Because in MAS patients, tissues as diverse as melanocytes, gonads and bone are affected, it is generally accepted that the GNAS mutation in this disease must have occurred early in development. Interestingly, it has been shown that the development of an active FD lesion may require both normal and mutant cells. Studies of the somatic mosaic states of FD/MAS and many other somatic diseases need an accurate method to determine the ratio of mutant to normal cells in a given tissue. A new method for quantification of the mutant:normal ratio of cells using a PNA hybridization probe-based FRET technique was developed. This novel technique, with a linear sensitivity of 2.5% mutant alleles, was used to detect the percentage mutant cells in a number of tissue and cell culture samples derived from FD/MAS lesions and could easily be adapted for the quantification of mutations in a large spectrum of diseases including cancer.
机译:体细胞突变以多种比例存在于许多发育病理中。先前已显示,编码Gsα蛋白的GNAS基因的体细胞激活错义突变是导致骨骼纤维发育异常(FD)/ McCune-Albright综合征(MAS)的原因。因为在MAS患者中,黑色素细胞,性腺和骨骼等各种组织都受到了影响,因此,人们普遍认为该疾病的GNAS突变一定是在发育的早期发生的。有趣的是,已经显示出活跃的FD病变的发展可能需要正常细胞和突变细胞。 FD / MAS和许多其他体细胞疾病的体细胞镶嵌状态的研究需要一种准确的方法来确定给定组织中突变体与正常细胞的比率。建立了一种新的定量突变体:正常细胞比例的方法,该方法使用了基于PNA杂交探针的FRET技术。这项线性灵敏度为2.5%突变等位基因的新技术用于检测来自FD / MAS病变的许多组织和细胞培养样品中突变细胞的百分比,并且可以轻松地用于大量突变的定量分析包括癌症在内的各种疾病。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号